Developer of a multi-omics liquid biopsy platform to advance precision cancer medicine

About the team:
The laboratory of Prof. Vermeesch translates and implements novel precision technologies to improve patient care. We use liquid biopsies as a biomarker to monitor and provide early detection of genic and non-genic diseases. Wouter Bossuyt is manager of the genomics core facility and develops NGS technology.

Website unit

Responsibilities

Project background: 
Genomic medicine moves healthcare from being reactive to disease to being predictive to disease onset or from cure to prevention. Next-generation sequencing technologies have leveraged novel concepts to diagnose, treat and monitor diseases. Analysis of free-floating cfDNA from blood or other body fluids - called “liquid biopsy” -represents an emerging tool that enables non-invasive monitoring of tissue dynamics in multiple human physiological and pathological conditions, including pregnancy, cancer and other conditions. In the ONCNGS project we are developing innovative approaches for (epi)genome-wide cfDNA analysis that can lead to novel applications to monitor cancer. In this project you will help build novel pipelines and perform clinical validation studies demonstrating the value of the new approaches.

The position: 
A bio-IT/Software engineer position to advance the development of a multi-omics liquid biopsy platform.  You will be integrated in a development team and work towards productization and commercialization.  We envision this 2 year academic position to evolve into a long term commercial position.

Profile

Offer

Interested?

For more information please contact Prof. dr. Joris Vermeesch, mail: joris.vermeesch@kuleuven.be

KU Leuven strives for an inclusive, respectful and socially safe environment. We embrace diversity among individuals and groups as an asset. Open dialogue and differences in perspective are essential for an ambitious research and educational environment. In our commitment to equal opportunity, we recognize the consequences of historical inequalities. We do not accept any form of discrimination based on, but not limited to, gender identity and expression, sexual orientation, age, ethnic or national background, skin colour, religious and philosophical diversity, neurodivergence, employment disability, health, or socioeconomic status. For questions about accessibility or support offered, we are happy to assist you at this email address.